alp staining solution Search Results


90
FUJIFILM labassaytm alp, alkaline phosphatase
Labassaytm Alp, Alkaline Phosphatase, supplied by FUJIFILM, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/alp+staining+solution/alkaline+phosphatase++alp++staining+solution/pm37091341-58-6-10
Average 90 stars, based on 1 article reviews
labassaytm alp, alkaline phosphatase - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Linaris GmbH horseradish peroxidase labelled secondary antibodies and alp or peroxidase substrate solutions vectastain® abc-ap staining kit
Horseradish Peroxidase Labelled Secondary Antibodies And Alp Or Peroxidase Substrate Solutions Vectastain® Abc Ap Staining Kit, supplied by Linaris GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/alp+staining+solution/horseradish+peroxidase+labelled+secondary+antibodies+and+alp+or+peroxidase+substrate+solutions+vectastain++abc+ap+staining+kit/pmc06651223-190-11-22
Average 90 stars, based on 1 article reviews
horseradish peroxidase labelled secondary antibodies and alp or peroxidase substrate solutions vectastain® abc-ap staining kit - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Yeasen Biotechnology alp staining solution
Alp Staining Solution, supplied by Yeasen Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/alp+staining+solution/alp+staining+solution/pm29144723__am7b13167_si_001-60-18-21
Average 90 stars, based on 1 article reviews
alp staining solution - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Nanjing Jiancheng Bioengineering Research Institute Co Ltd alp staining solution
Isolation and osteogenic differentiation of BMSCs (A) Normal and osteoporotic BMSCs were isolated from normal and osteoporotic bone marrow tissues, respectively (the scale bar is 50 μm). (B) Flow cytometry was performed to identify isolated BMSCs detecting CD34, CD45, CD73, CD90, and CD105. (C) Normal and osteoporotic BMSCs were induced towards osteogenic differentiation for 21 days, and the protein levels of <t>ALP,</t> OCN, Runx2, and Osterix were examined using Immunoblotting on days 0, 7, and 14 of osteogenic induction (C) ; <t>ALP</t> <t>staining</t> was performed on day 0, 7, and 14 of osteogenic induction (D) ; the formation of mineralized nodules were examined using Alizarin red staining on days 0 and 21 of osteogenic induction (E) ; the expression of miR-4739 was examined using qRT-PCR on day 0, 3, and 7 of osteogenic induction in normal BMSCs and osteoporotic BMSCs (F) . n=3, **p < 0.01 compared to OP-BMSC. aa p<0.01 compared between 0 days OP-BMSC and 3 days OP-BMSC; bb p < 0.01 compared between 0 days normal-BMSC and 3 days normal-BMSC; cc p<0.01 compared between 0 days OP-BMSC and 14 days OP-BMSC; dd p < 0.01 compared between 0 days normal-BMSC and 14 days normal-BMSC.
Alp Staining Solution, supplied by Nanjing Jiancheng Bioengineering Research Institute Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/alp+staining+solution/alp+staining+solution/pmc08678599-59-31-34
Average 90 stars, based on 1 article reviews
alp staining solution - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

86
Applygen Technologies alp staining solution
Isolation and osteogenic differentiation of BMSCs (A) Normal and osteoporotic BMSCs were isolated from normal and osteoporotic bone marrow tissues, respectively (the scale bar is 50 μm). (B) Flow cytometry was performed to identify isolated BMSCs detecting CD34, CD45, CD73, CD90, and CD105. (C) Normal and osteoporotic BMSCs were induced towards osteogenic differentiation for 21 days, and the protein levels of <t>ALP,</t> OCN, Runx2, and Osterix were examined using Immunoblotting on days 0, 7, and 14 of osteogenic induction (C) ; <t>ALP</t> <t>staining</t> was performed on day 0, 7, and 14 of osteogenic induction (D) ; the formation of mineralized nodules were examined using Alizarin red staining on days 0 and 21 of osteogenic induction (E) ; the expression of miR-4739 was examined using qRT-PCR on day 0, 3, and 7 of osteogenic induction in normal BMSCs and osteoporotic BMSCs (F) . n=3, **p < 0.01 compared to OP-BMSC. aa p<0.01 compared between 0 days OP-BMSC and 3 days OP-BMSC; bb p < 0.01 compared between 0 days normal-BMSC and 3 days normal-BMSC; cc p<0.01 compared between 0 days OP-BMSC and 14 days OP-BMSC; dd p < 0.01 compared between 0 days normal-BMSC and 14 days normal-BMSC.
Alp Staining Solution, supplied by Applygen Technologies, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/alp+staining+solution/alp+solution+staining/pm41579836-114-4-7
Average 86 stars, based on 1 article reviews
alp staining solution - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

Image Search Results


Isolation and osteogenic differentiation of BMSCs (A) Normal and osteoporotic BMSCs were isolated from normal and osteoporotic bone marrow tissues, respectively (the scale bar is 50 μm). (B) Flow cytometry was performed to identify isolated BMSCs detecting CD34, CD45, CD73, CD90, and CD105. (C) Normal and osteoporotic BMSCs were induced towards osteogenic differentiation for 21 days, and the protein levels of ALP, OCN, Runx2, and Osterix were examined using Immunoblotting on days 0, 7, and 14 of osteogenic induction (C) ; ALP staining was performed on day 0, 7, and 14 of osteogenic induction (D) ; the formation of mineralized nodules were examined using Alizarin red staining on days 0 and 21 of osteogenic induction (E) ; the expression of miR-4739 was examined using qRT-PCR on day 0, 3, and 7 of osteogenic induction in normal BMSCs and osteoporotic BMSCs (F) . n=3, **p < 0.01 compared to OP-BMSC. aa p<0.01 compared between 0 days OP-BMSC and 3 days OP-BMSC; bb p < 0.01 compared between 0 days normal-BMSC and 3 days normal-BMSC; cc p<0.01 compared between 0 days OP-BMSC and 14 days OP-BMSC; dd p < 0.01 compared between 0 days normal-BMSC and 14 days normal-BMSC.

Journal: Frontiers in Endocrinology

Article Title: The miR-4739/DLX3 Axis Modulates Bone Marrow-Derived Mesenchymal Stem Cell (BMSC) Osteogenesis Affecting Osteoporosis Progression

doi: 10.3389/fendo.2021.703167

Figure Lengend Snippet: Isolation and osteogenic differentiation of BMSCs (A) Normal and osteoporotic BMSCs were isolated from normal and osteoporotic bone marrow tissues, respectively (the scale bar is 50 μm). (B) Flow cytometry was performed to identify isolated BMSCs detecting CD34, CD45, CD73, CD90, and CD105. (C) Normal and osteoporotic BMSCs were induced towards osteogenic differentiation for 21 days, and the protein levels of ALP, OCN, Runx2, and Osterix were examined using Immunoblotting on days 0, 7, and 14 of osteogenic induction (C) ; ALP staining was performed on day 0, 7, and 14 of osteogenic induction (D) ; the formation of mineralized nodules were examined using Alizarin red staining on days 0 and 21 of osteogenic induction (E) ; the expression of miR-4739 was examined using qRT-PCR on day 0, 3, and 7 of osteogenic induction in normal BMSCs and osteoporotic BMSCs (F) . n=3, **p < 0.01 compared to OP-BMSC. aa p<0.01 compared between 0 days OP-BMSC and 3 days OP-BMSC; bb p < 0.01 compared between 0 days normal-BMSC and 3 days normal-BMSC; cc p<0.01 compared between 0 days OP-BMSC and 14 days OP-BMSC; dd p < 0.01 compared between 0 days normal-BMSC and 14 days normal-BMSC.

Article Snippet: BMSCs were cultured in an osteogenic induction culture medium (complete culture medium contains 5 mM β-glycerophosphate, 50 μM ascorbate, and 100 nM dexamethasone) for 14 days and were stained with the ALP staining solution (Nanjing Jiancheng, Nanjing, China) on day 0, 7, and 14 of osteogenic induction.

Techniques: Isolation, Flow Cytometry, Western Blot, Staining, Expressing, Quantitative RT-PCR

Effects of miR-4739 overexpression and inhibition on osteoporotic BMSC osteogenic differentiation (A) miR-4739 overexpression or inhibition was achieved in osteoporotic BMSCs by transfecting agomir-4739 or antagomir-4739; miR-4739 expression was confirmed using qRT-PCR. n=3. (B) Osteoporotic BMSCs were transfected with agomir-4739 or antagomir-4739 and examined for cell viability by CCK-8 assay (n=3). Then, osteoporotic BMSCs were transfected with agomir-4739 or antagomir-4739, induced towards osteogenic differentiation for 21 days, and examined using ALP staining on day 14 of osteogenic induction (C) ; examined for the formation of mineralized nodules using Alizarin red staining on day 21 of osteogenic induction (D) ; examined for the protein levels of ALP, OCN, Runx2, and Osterix using Immunoblotting on day 14 of osteogenic induction (E) (n=3). ** P < 0.01, compared to NC agomir; # P < 0.05, ## P < 0.01, compared to NC antagomir.

Journal: Frontiers in Endocrinology

Article Title: The miR-4739/DLX3 Axis Modulates Bone Marrow-Derived Mesenchymal Stem Cell (BMSC) Osteogenesis Affecting Osteoporosis Progression

doi: 10.3389/fendo.2021.703167

Figure Lengend Snippet: Effects of miR-4739 overexpression and inhibition on osteoporotic BMSC osteogenic differentiation (A) miR-4739 overexpression or inhibition was achieved in osteoporotic BMSCs by transfecting agomir-4739 or antagomir-4739; miR-4739 expression was confirmed using qRT-PCR. n=3. (B) Osteoporotic BMSCs were transfected with agomir-4739 or antagomir-4739 and examined for cell viability by CCK-8 assay (n=3). Then, osteoporotic BMSCs were transfected with agomir-4739 or antagomir-4739, induced towards osteogenic differentiation for 21 days, and examined using ALP staining on day 14 of osteogenic induction (C) ; examined for the formation of mineralized nodules using Alizarin red staining on day 21 of osteogenic induction (D) ; examined for the protein levels of ALP, OCN, Runx2, and Osterix using Immunoblotting on day 14 of osteogenic induction (E) (n=3). ** P < 0.01, compared to NC agomir; # P < 0.05, ## P < 0.01, compared to NC antagomir.

Article Snippet: BMSCs were cultured in an osteogenic induction culture medium (complete culture medium contains 5 mM β-glycerophosphate, 50 μM ascorbate, and 100 nM dexamethasone) for 14 days and were stained with the ALP staining solution (Nanjing Jiancheng, Nanjing, China) on day 0, 7, and 14 of osteogenic induction.

Techniques: Over Expression, Inhibition, Expressing, Quantitative RT-PCR, Transfection, CCK-8 Assay, Staining, Western Blot

Co-effects of the miR-4739/DLX3 axis on osteoporotic BMSC osteogenic differentiation (A) DLX3 knockdown was achieved in osteoporotic BMSCs by transfecting short hairpin RNA against DLX3 (sh1/2-DLX3); DLX3 knockdown was confirmed by qRT-PCR. n=3. Then, osteoporotic BMSCs were co-transfected with sh-DLX3 and antagomir-4739 and examined for the protein levels of DLX3 by Immunoblotting (B) and cell viability by CCK-8 assay (C) (n=3). Then, normal BMSCs were co-transfected with sh-DLX3 and antagomir-4739, induced towards osteogenic differentiation for 21 days, and examined using ALP staining on day 14 of osteogenic induction (D) ; the formation of mineralized nodules using Alizarin red staining on day 21 of osteogenic induction (E) ; the protein levels of ALP, OCN, Runx2, and Osterix using Immunoblotting on day 14 of osteogenic induction (F) . n=3. ** P < 0.01, ## P < 0.01.

Journal: Frontiers in Endocrinology

Article Title: The miR-4739/DLX3 Axis Modulates Bone Marrow-Derived Mesenchymal Stem Cell (BMSC) Osteogenesis Affecting Osteoporosis Progression

doi: 10.3389/fendo.2021.703167

Figure Lengend Snippet: Co-effects of the miR-4739/DLX3 axis on osteoporotic BMSC osteogenic differentiation (A) DLX3 knockdown was achieved in osteoporotic BMSCs by transfecting short hairpin RNA against DLX3 (sh1/2-DLX3); DLX3 knockdown was confirmed by qRT-PCR. n=3. Then, osteoporotic BMSCs were co-transfected with sh-DLX3 and antagomir-4739 and examined for the protein levels of DLX3 by Immunoblotting (B) and cell viability by CCK-8 assay (C) (n=3). Then, normal BMSCs were co-transfected with sh-DLX3 and antagomir-4739, induced towards osteogenic differentiation for 21 days, and examined using ALP staining on day 14 of osteogenic induction (D) ; the formation of mineralized nodules using Alizarin red staining on day 21 of osteogenic induction (E) ; the protein levels of ALP, OCN, Runx2, and Osterix using Immunoblotting on day 14 of osteogenic induction (F) . n=3. ** P < 0.01, ## P < 0.01.

Article Snippet: BMSCs were cultured in an osteogenic induction culture medium (complete culture medium contains 5 mM β-glycerophosphate, 50 μM ascorbate, and 100 nM dexamethasone) for 14 days and were stained with the ALP staining solution (Nanjing Jiancheng, Nanjing, China) on day 0, 7, and 14 of osteogenic induction.

Techniques: Knockdown, shRNA, Quantitative RT-PCR, Transfection, Western Blot, CCK-8 Assay, Staining